Reversing Transplant Ineligibility With Teclistamab in Ultra–High-Risk Relapsed/Refractory Multiple Myeloma With Extramedullary Disease

Clinical Lymphoma Myeloma & Leukemia 2026

View at publisher

Authors: Rudra Narayan Swain, Sarthak Wadhera, Aditya Jandial, Charanpreet Singh, Arihant Jain, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra

DOI: 10.1016/j.clml.2026.02.010

Cited by: 1

References: 10

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Acute Myeloid Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment

References 10